Anti-Human CD19 Recombinant Antibody(Inebilizumab)

Name: Anti-Human CD19 Recombinant Antibody(Inebilizumab)
Brand: KMD Bioscience
SKU: YR1374

YR1374

科研级 Inebilizumab ( 英比利珠单抗 ), Anti-CD19 Recombinant Antibody, Research Grade Inebilizumab

DATASHEET MSDS

Product Description

Alias	科研级 Inebilizumab ( 英比利珠单抗 ), Anti-CD19 Recombinant Antibody, Research Grade Inebilizumab
Catalog Number	YR1374
Molecular Name	Inebilizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Inebilizumab, sold under the brand name Uplizna, is a medication for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults.The most common adverse reactions include urinary tract infection, headache, joint pain (arthralgia), nausea and back pain.
CAS Number	1299440-37-1
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD19[Homo sapiens]

Login